We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$9.59B
AUM Growth
+$2.64B
Cap. Flow
+$1.86B
Cap. Flow %
19.38%
Top 10 Hldgs %
41.45%
Holding
182
New
66
Increased
33
Reduced
26
Closed
49

Sector Composition

Rank Sector Weight
1 Communication Services 18.19%
2 Energy 11.57%
3 Financials 10.79%
4 Healthcare 10.61%
5 Technology 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRS icon
101
Coherus Oncology
CHRS
$217M
$8.91M 0.09%
+421,300
New +$10.4M
SIOX
102
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$8.61M 0.09%
72,050
+22,050
+44% +$2.31M
EOG icon
103
EOG Resources
EOG
$77.2B
$8.42M 0.09%
+86,350
New +$8.61M
HBAN icon
104
Huntington Bancshares
HBAN
$34.3B
$8.11M 0.08%
605,500
-1,012,000
-63% -$13.8M
RXDX
105
DELISTED
Ignyta, Inc.
RXDX
$6.07M 0.06%
+706,200
New +$5.16M
RVNC
106
DELISTED
Revance Therapeutics, Inc.
RVNC
$5.75M 0.06%
276,500
+101,500
+58% +$2.08M
BPMC
107
DELISTED
Blueprint Medicines
BPMC
$5.18M 0.05%
+129,500
New +$4.64M
RAI
108
DELISTED
Reynolds American Inc
RAI
$5.04M 0.05%
+80,000
New +$4.81M
TMUS icon
109
CALL
T-Mobile US
TMUS
$194B
$4.84M 0.05%
+75,000
New +$4.61M
BIO icon
110
Bio-Rad Laboratories Class A
BIO
$8.79B
$4.01M 0.04%
+20,100
New +$3.87M
LOXO
111
DELISTED
Loxo Oncology, Inc
LOXO
$3.85M 0.04%
+91,600
New +$3.77M
NIHD
112
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$3.76M 0.04%
+2,894,900
New +$6.26M
V icon
113
Visa
V
$709B
$3.53M 0.04%
+39,700
New +$3.42M
BABA icon
114
Alibaba
BABA
$276B
$3.3M 0.03%
+30,600
New +$3.11M
GCVRZ
115
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.29M 0.03%
7,305,164
SYT
116
DELISTED
Syngenta Ag
SYT
$3.1M 0.03%
+35,000
New +$3M
BIIB icon
117
CALL
Biogen
BIIB
$31B
$2.73M 0.03%
+10,000
New +$2.83M
VZ icon
118
Verizon
VZ
$201B
$2.44M 0.03%
+50,000
New +$2.51M
CMA
119
DELISTED
Comerica
CMA
$2.08M 0.02%
30,300
-441,900
-94% -$30.8M
XLV icon
120
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.1B
$1.86M 0.02%
+25,000
New +$1.82M
CI icon
121
Cigna
CI
$78.8B
$1.83M 0.02%
+12,500
New +$1.84M
ARAV
122
DELISTED
Aravive, Inc. Common Stock
ARAV
$1.78M 0.02%
+13,903
New +$1.47M
CSC
123
PUT
DELISTED
Computer Sciences
CSC
$1.73M 0.02%
+25,000
New +$1.66M
PXD
124
DELISTED
Pioneer Natural Resource Co.
PXD
$987K 0.01%
5,300
-25,300
-83% -$4.69M
WLK icon
125
Westlake Corp
WLK
$9.26B
$905K 0.01%
13,700
-728,300
-98% -$46.1M

Similar funds

PointState Capital's Q1 2017 Portfolio in Review

As of Q1 2017, PointState Capital held 182 positions worth $9.59B, up 38% from $6.95B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

PointState Capital deployed $1.86B of net new capital in Q1 2017, opening 66 new positions and adding to 33 existing holdings. Its largest new stake was DuPont de Nemours: 3,776,539 shares worth $608M.

By sector, the portfolio is most concentrated in Communication Services at 18% of assets, up from 7.4% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was LyondellBasell Industries, an estimated $448M trimmed.

  • PointState Capital's largest Q1 2017 buy was DuPont de Nemours: 3,776,539 shares worth $608M.
  • PointState Capital added most to Meta Platforms (Facebook) in Q1 2017, an estimated $343M increase.
  • PointState Capital's biggest Q1 2017 reduction was LyondellBasell Industries, cutting an estimated $448M.
  • PointState Capital fully exited KeyCorp in Q1 2017, selling an estimated $188M.
  • PointState Capital's ten largest holdings make up 41% of its $9.59B portfolio in Q1 2017.
  • PointState Capital opened 66 new positions and closed 49 in Q1 2017.
  • PointState Capital's portfolio value rose 38% quarter-over-quarter to $9.59B.

Based on PointState Capital's 13F filing for Q1 2017, filed 15 May 2017.